Progyny, a New York-based digital health care company specialising in fertility and in-vitro fertilisation has closed its Series B fundraising round having raised nearly $15 million. This comes at the same time as the company launched its mobile app which offers a comprehensive and personal experience for consumers seeking fertilisation services. The app will help connect consumers with fertilisation services in the local area based on their needs, showing the potential options and their prices.
Progyny, a New York-based digital health care company specialising in fertility and in-vitro fertilisation has closed its Series B fundraising round having raised close to $15m. This comes at the same time as the company launched its mobile app which offers a comprehensive and personal experience for consumers seeking fertilisation services. The app will help connect consumers with fertilisation services in the local area based on their needs, showing the potential options and their prices.